# Benzonatate

NDC: 76420-803
Generic name: Benzonatate
Labeler / Manufacturer: Asclemed USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20181221

FDA application: ANDA206948

## Active ingredients

- BENZONATATE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76420-803"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76420-803
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=25ed5206-b322-486f-9e54-14125f6e74c5